Literature DB >> 29084060

Characterization of PD-L1 Immunohistochemical Expression in Cell Blocks With Different Specimen Fixation and Processing Methods.

Isaac E Lloyd1, Wenhua Zhou2, Benjamin L Witt1, Barbara E Chadwick1.   

Abstract

Interpretative criteria for programmed death-ligand 1 (PD-L1) immunohistochemistry (IHC) have been largely based on data from formalin-fixed, paraffin-embedded tissues, despite the fact that cytologic specimens, especially cell blocks, are often the only or most readily available tissue for testing. Unlike biopsy specimens, however, cytology sample processing methods can vary markedly. The purpose of this study was to evaluate the effects of several common preanalytic variables on PD-L1 IHC. Two cell lines with strong expression of PD-L1 (H441) and no expression (MCF7) were cultured in vitro. Harvested cells were collected in PreservCyt, CytoLyt, cell culture media (RPMI), saline, and formalin. Cell blocks were prepared by the plasma-thromboplastin method or Cellient automated system and stained with the FDA-approved 28-8 PD-L1 antibody per protocol. PD-L1 expression was scored manually by 3 pathologists for stain intensity and localization and compared across preparation methods. Several IHC staining patterns were observed: complete membranous, partial membranous, globular, and cytoplasmic, with some overlap. Cellient blocks had the best interobserver agreement and cytomorphology, highest proportion of strong complete membranous staining (82%), and least amount of cytoplasmic (11%) and globular staining (8%). RPMI, saline, and formalin samples demonstrated increased amounts of cytoplasmic and globular staining relative to Cellient, while CytoLyt exhibited the poorest performance overall. Interpretation of PD-L1 IHC on cell blocks is feasible for most processing methods examined, but may require recognition of increased cytoplasmic and globular staining in some sample types. Cellient cell blocks demonstrated superior performance compared with other methods.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 29084060     DOI: 10.1097/PAI.0000000000000572

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  11 in total

Review 1.  Predictive biomarkers for response to immune checkpoint inhibitors in lung cancer: PD-L1 and beyond.

Authors:  Hironori Uruga; Mari Mino-Kenudson
Journal:  Virchows Arch       Date:  2021-01-24       Impact factor: 4.064

2.  Comparison of PD-L1 expression between paired cytologic and histologic specimens from non-small cell lung cancer patients.

Authors:  C Kuempers; L I S van der Linde; M Reischl; W Vogel; F Stellmacher; M Reck; D Heigener; K F Rabe; J Kirfel; S Perner; L Welker
Journal:  Virchows Arch       Date:  2019-08-07       Impact factor: 4.064

Review 3.  Immunocytochemistry for predictive biomarker testing in lung cancer cytology.

Authors:  Deepali Jain; Aruna Nambirajan; Alain Borczuk; Gang Chen; Yuko Minami; Andre L Moreira; Noriko Motoi; Mauro Papotti; Natasha Rekhtman; Prudence A Russell; Spasenija Savic Prince; Yasushi Yatabe; Lukas Bubendorf
Journal:  Cancer Cytopathol       Date:  2019-05-03       Impact factor: 5.284

4.  The International Association for the Study of Lung Cancer Global Survey on Programmed Death-Ligand 1 Testing for NSCLC.

Authors:  Mari Mino-Kenudson; Nolwenn Le Stang; Jillian B Daigneault; Andrew G Nicholson; Wendy A Cooper; Anja C Roden; Andre L Moreira; Erik Thunnissen; Mauro Papotti; Giuseppe Pelosi; Noriko Motoi; Claudia Poleri; Elisabeth Brambilla; Mary Redman; Deepali Jain; Sanja Dacic; Yasushi Yatabe; Ming Sound Tsao; Fernando Lopez-Rios; Johan Botling; Gang Chen; Teh-Ying Chou; Fred R Hirsch; Mary Beth Beasley; Alain Borczuk; Lukas Bubendorf; Jin-Haeng Chung; David Hwang; Dongmei Lin; John Longshore; Masayuki Noguchi; Natasha Rekhtman; Lynette Sholl; William Travis; Akihiko Yoshida; Murry W Wynes; Ignacio I Wistuba; Keith M Kerr; Sylvie Lantuejoul
Journal:  J Thorac Oncol       Date:  2021-03-02       Impact factor: 20.121

Review 5.  Cell-blocks and immunohistochemistry.

Authors:  Vinod B Shidham; Lester J Layfield
Journal:  Cytojournal       Date:  2021-01-30       Impact factor: 2.091

6.  Study on PD-L1 Expression in NSCLC Patients and Related Influencing Factors in the Real World.

Authors:  Yefei Zhu; Shuangxiang Lin; Yueping Wang; Bingxiao Shen; Ling Lin; Liangxing Wang; Susu He
Journal:  Comput Math Methods Med       Date:  2021-12-28       Impact factor: 2.238

7.  Formalin fixation for optimal concordance of programmed death-ligand 1 immunostaining between cytologic and histologic specimens from patients with non-small cell lung cancer.

Authors:  Bregje M Koomen; Jose van der Starre-Gaal; Judith M Vonk; Jan H von der Thüsen; Jacqueline J C van der Meij; Kim Monkhorst; Stefan M Willems; Wim Timens; Nils A 't Hart
Journal:  Cancer Cytopathol       Date:  2020-10-27       Impact factor: 5.284

8.  Influence of preanalytical variables on performance of delta-like protein 3 (DLL3) predictive immunohistochemistry.

Authors:  Teodora Radonic; S Duin; W Vos; P Kortman; Aeilko H Zwinderman; Erik Thunnissen
Journal:  Virchows Arch       Date:  2020-06-02       Impact factor: 4.064

Review 9.  PD-L1 and beyond: Immuno-oncology in cytopathology.

Authors:  Antonino Iaccarino; Maria Salatiello; Ilaria Migliatico; Caterina De Luca; Gianluca Gragnano; Maria Russo; Claudio Bellevicine; Umberto Malapelle; Giancarlo Troncone; Elena Vigliar
Journal:  Cytopathology       Date:  2021-05-06       Impact factor: 2.073

10.  False-negative programmed death-ligand 1 immunostaining in ethanol-fixed endobronchial ultrasound-guided transbronchial needle aspiration specimens of non-small-cell lung cancer patients.

Authors:  Bregje M Koomen; Willem Vreuls; Mirthe de Boer; Emma J de Ruiter; Juergen Hoelters; Aryan Vink; Stefan M Willems
Journal:  Histopathology       Date:  2021-06-08       Impact factor: 5.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.